Zura Bio Ltd. (ZURA)
6.97
+0.21
(+3.11%)
USD |
NASDAQ |
Mar 06, 16:00
6.95
-0.02
(-0.29%)
After-Hours: 20:00
Zura Bio EPS Diluted (Quarterly) : -0.2119 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rapt Therapeutics, Inc. | -0.652 |
| Disc Medicine, Inc. | -1.618 |
| Amylyx Pharmaceuticals, Inc. | -0.3004 |
| Apogee Therapeutics, Inc. | -1.026 |
| Eli Lilly & Co. | 7.024 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.04M |
| Total Expenses (Quarterly) | 20.04M |
| Enterprise Value | 324.40M |
| Earnings Yield | -10.15% |
| Normalized Earnings Yield | -10.15 |